MYONEXUS THERAPEUTICS

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) Types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a global leader in muscular dystrophy gene therapy discovery and translational research.

#SimilarOrganizations #People #Financial #Website #More

MYONEXUS THERAPEUTICS

Social Links:

Industry:

Biotechnology Health Care Therapeutics

Founded:

2017-02-01

Address:

Columbus, Ohio, United States

Country:

United States

Website Url:

http://www.myonexustx.com

Total Employee:

Status:

Active

Contact:

614.477.5445

Email Addresses:

[email protected]

Total Funding:

62.5 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail Google Maps Google Maps API Google Maps For Work CSC Global DNS

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

harpoon-therapeutics-logo

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system

Current Advisors List

wayne-embree_image

Wayne Embree Board Member @ Myonexus Therapeutics
Board_member

Founder

michael-triplett_image

Michael Triplett

Investors List

sarepta-therapeutics_image

Official Site Inspections

http://www.myonexustx.com

Host Informations
Whois Informations

Loading ...